Yu Hong Geng
Keine laufenden Positionen mehr
Profil
Yu Hong Geng served as a Member-Supervisory Board at BIOTON SA. Later, from 2014 to 2021, Geng worked as a Vice President at Shanghai United Cell Biotechnology Co. Ltd.
Geng holds a doctorate degree from the University of Hong Kong, which was conferred in 2002.
Additionally, Geng holds a graduate degree from Fudan University, which was conferred in 1996.
Ehemalige bekannte Positionen von Yu Hong Geng
Unternehmen | Position | Ende |
---|---|---|
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2014 |
BIOTON S.A. | Direktor/Vorstandsmitglied | - |
Ausbildung von Yu Hong Geng
University of Hong Kong | Doctorate Degree |
Fudan University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOTON S.A. | Health Technology |
Private Unternehmen | 1 |
---|---|
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Health Technology |